Veno-arterial CO2 Pressure Difference to Arterio-venous O2 Difference Ratio & Blood Lactate Levels Are Predictors of Postoperative Outcome in Whipple Procedures

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAlexandria University

About this trial

Whipple surgery is a complex abdominal procedure associated with a high risk of hemodynamic instability and splanchnic hypoperfusion leading to anastomotic leaks, delayed gastric emptying, and organ dysfunction Traditional markers (e.g., MAP, mixed venous oxygen saturation \[SvO₂\], lactate) are indirect, invasive and often delayed.

CO₂-derived variables (e.g., venous-to-arterial CO₂ gap \[ΔCO₂\], tissue CO₂ \[PtCO₂\], end-tidal CO₂ \[EtCO₂\] changes) provide earlier and more sensitive signs of microcirculatory dysfunction.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults (>18 years) undergoing open Whipple procedure under general anesthesia

Invasive monitoring (arterial line and central venous catheter)

Informed written consent

Disqualifiers

Emergency surgery.

Preoperative septic shock or hemodynamic instability.

severe pre-existing **cardiopulmonary disease (e.g., severe COPD, heart failure).

Trial design

Design model

Single group

Treatments tested in this trial

  • predictors of postoperative outcome in Whipple Procedures

    Other intervention

    CO₂-Derived Parameters \& Lactate as Predictors of Postoperative outcome in Whipple Procedures and the occurrence of complications

Treatment groups

120 Participants
are divided into 1 treatment group
Group A: Predictors of Postoperative outcome in Whipple ProceduresOther 1 intervention

Trial outcomes

Primary outcomes

1

Venous-to-Arterial CO₂ Gap (Pv-aCO₂ = PvCO₂ - PaCO₂)

Measured via arterial and central venous blood gases sampling throughout the Whipple procedure

Time frame
T0 baseline (After induction of anesthesia) T1 intraoperative (After major vessel dissection) T2 intraoperative (Immediately post-pancreatic resection) T3 intraoperative (After GIT anastomosis) T4 End of surgery T5 postoperative (2 hours)
2

Arterial-Venous oxygen content difference (Ca-vO₂ = CaO₂ - CvO₂)

Measured via arterial and central venous blood gases

Time frame
T0 baseline (After induction of anesthesia) T1 intraoperative (After major vessel dissection) T2 intraoperative (Immediately post-pancreatic resection) T3 intraoperative (After GIT anastomosis) T4 End of surgery T5 postoperative (2 hours) in ICU
3

Veno-arterial CO2 Pressure Difference to Arterio-venous O2 Difference Ratio (Pv-aCO₂/Ca-vO₂ ratio )

calculated by dividing the previous 2 measurements (Pv-aCO₂/Ca-vO₂ )

Time frame
T0 baseline (After induction of anesthesia) T1 intraoperative (After major vessel dissection) T2 intraoperative (Immediately post-pancreatic resection) T3 intraoperative (After GIT anastomosis) T4 End of surgery T5 postoperative (2 hours) in ICU

Secondary outcomes

1

Traditional Perfusion Markers :Lactate

Measured via arterial blood gases sampling

Time frame
T0 baseline (After induction of anesthesia) T1 intraoperative (After major vessel dissection) T2 intraoperative (Immediately post-pancreatic resection) T3 intraoperative (After GIT anastomosis) T4 End of surgery T5 postoperative (2 hours) in ICU
2

occurrence of Postoperative complications

• Anastomotic leak rate (pancreaticojejunostomy, hepaticojejunostomy), Delayed gastric emptying (DGE), Postoperative pancreatic fistula (POPF),

Time frame
within 3 days in ICU for complications, 30 days postoperatively for mortality
3

ICU length of stay

total ICU stay ( days)

Time frame
postoperative 3 days
4

Occurrence of post-operative complications

30-day mortality

Time frame
postoperatively within 1 month

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: